Selected research
Industry Growth & Trends
Global Cinnarizine Tablets Industry Growth and Trends Forecast to 2032
Market perspective
The global Cinnarizine Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Cinnarizine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Cinnarizine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Cinnarizine Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Cinnarizine Tablets include Actavis, Bristol Myers Squibb, Glenmark Pharmaceuticals, Johnson & Johnson, McNeil Products, Peak Pharmacy, Sanofi, Teva Pharmaceuticals and Torrent Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Cinnarizine Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Cinnarizine Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cinnarizine Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cinnarizine Tablets.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Cinnarizine Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Cinnarizine Tablets Market by Company
Actavis
Bristol Myers Squibb
Glenmark Pharmaceuticals
Johnson & Johnson
McNeil Products
Peak Pharmacy
Sanofi
Teva Pharmaceuticals
Torrent Pharmaceuticals
Beijing Neptunus Zhongxin Pharmaceutical
Cisen Pharma
Harbin Pharmaceutical Group
Nanjing Baijingyu Pharmaceutical
Shanghai Xinyi Wanxiang Pharmaceutical
CSPC
Cinnarizine Tablets Segment by Type
15mg per Tablet
25mg per Tablet
Cinnarizine Tablets Segment by Application
Hospital and Clinic
Retail Pharmacies
Other
Cinnarizine Tablets Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cinnarizine Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cinnarizine Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cinnarizine Tablets.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cinnarizine Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Cinnarizine Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 15mg per Tablet
- 25mg per Tablet
Applications
- Hospital and Clinic
- Retail Pharmacies
- Other
Companies covered
- Actavis
- Bristol Myers Squibb
- Glenmark Pharmaceuticals
- Johnson & Johnson
- McNeil Products
- Peak Pharmacy
- Sanofi
- Teva Pharmaceuticals
- Torrent Pharmaceuticals
- Beijing Neptunus Zhongxin Pharmaceutical
- Cisen Pharma
- Harbin Pharmaceutical Group
- Nanjing Baijingyu Pharmaceutical
- Shanghai Xinyi Wanxiang Pharmaceutical
- CSPC
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Cinnarizine Tablets Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Cinnarizine Tablets Sales Estimates and Forecasts (2021-2032)
- 1.3 Cinnarizine Tablets Market by Type
- 1.3.1 15mg per Tablet
- 1.3.2 25mg per Tablet
- 1.4 Global Cinnarizine Tablets Market Size by Type
- 1.4.1 Global Cinnarizine Tablets Market Size Overview by Type (2021-2032)
- 1.4.2 Global Cinnarizine Tablets Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Cinnarizine Tablets Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Cinnarizine Tablets Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Cinnarizine Tablets Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Cinnarizine Tablets Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Cinnarizine Tablets Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Cinnarizine Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Cinnarizine Tablets Industry Trends
- 2.2 Cinnarizine Tablets Industry Drivers
- 2.3 Cinnarizine Tablets Industry Opportunities and Challenges
- 2.4 Cinnarizine Tablets Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Cinnarizine Tablets Revenue (2021-2026)
- 3.2 Global Top Players by Cinnarizine Tablets Sales (2021-2026)
- 3.3 Global Top Players by Cinnarizine Tablets Price (2021-2026)
- 3.4 Global Cinnarizine Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Cinnarizine Tablets Major Company Production Sites & Headquarters
- 3.6 Global Cinnarizine Tablets Company, Product Type & Application
- 3.7 Global Cinnarizine Tablets Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Cinnarizine Tablets Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Cinnarizine Tablets Players Market Share by Revenue in 2025
- 3.8.3 2025 Cinnarizine Tablets Tier 1, Tier 2, and Tier 3
4 Cinnarizine Tablets Regional Status and Outlook
- 4.1 Global Cinnarizine Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Cinnarizine Tablets Historic Market Size by Region
- 4.2.1 Global Cinnarizine Tablets Sales in Volume by Region (2021-2026)
- 4.2.2 Global Cinnarizine Tablets Sales in Value by Region (2021-2026)
- 4.2.3 Global Cinnarizine Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Cinnarizine Tablets Forecasted Market Size by Region
- 4.3.1 Global Cinnarizine Tablets Sales in Volume by Region (2027-2032)
- 4.3.2 Global Cinnarizine Tablets Sales in Value by Region (2027-2032)
- 4.3.3 Global Cinnarizine Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cinnarizine Tablets by Application
- 5.1 Cinnarizine Tablets Market by Application
- 5.1.1 Hospital and Clinic
- 5.1.2 Retail Pharmacies
- 5.1.3 Other
- 5.2 Global Cinnarizine Tablets Market Size by Application
- 5.2.1 Global Cinnarizine Tablets Market Size Overview by Application (2021-2032)
- 5.2.2 Global Cinnarizine Tablets Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Cinnarizine Tablets Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Cinnarizine Tablets Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Cinnarizine Tablets Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Cinnarizine Tablets Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Cinnarizine Tablets Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Cinnarizine Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Actavis
- 6.1.1 Actavis Company Information
- 6.1.2 Actavis Business Overview
- 6.1.3 Actavis Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Actavis Cinnarizine Tablets Product Portfolio
- 6.1.5 Actavis Recent Developments
- 6.2 Bristol Myers Squibb
- 6.2.1 Bristol Myers Squibb Company Information
- 6.2.2 Bristol Myers Squibb Business Overview
- 6.2.3 Bristol Myers Squibb Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Bristol Myers Squibb Cinnarizine Tablets Product Portfolio
- 6.2.5 Bristol Myers Squibb Recent Developments
- 6.3 Glenmark Pharmaceuticals
- 6.3.1 Glenmark Pharmaceuticals Company Information
- 6.3.2 Glenmark Pharmaceuticals Business Overview
- 6.3.3 Glenmark Pharmaceuticals Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Glenmark Pharmaceuticals Cinnarizine Tablets Product Portfolio
- 6.3.5 Glenmark Pharmaceuticals Recent Developments
- 6.4 Johnson & Johnson
- 6.4.1 Johnson & Johnson Company Information
- 6.4.2 Johnson & Johnson Business Overview
- 6.4.3 Johnson & Johnson Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Johnson & Johnson Cinnarizine Tablets Product Portfolio
- 6.4.5 Johnson & Johnson Recent Developments
- 6.5 McNeil Products
- 6.5.1 McNeil Products Company Information
- 6.5.2 McNeil Products Business Overview
- 6.5.3 McNeil Products Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 McNeil Products Cinnarizine Tablets Product Portfolio
- 6.5.5 McNeil Products Recent Developments
- 6.6 Peak Pharmacy
- 6.6.1 Peak Pharmacy Company Information
- 6.6.2 Peak Pharmacy Business Overview
- 6.6.3 Peak Pharmacy Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Peak Pharmacy Cinnarizine Tablets Product Portfolio
- 6.6.5 Peak Pharmacy Recent Developments
- 6.7 Sanofi
- 6.7.1 Sanofi Company Information
- 6.7.2 Sanofi Business Overview
- 6.7.3 Sanofi Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Sanofi Cinnarizine Tablets Product Portfolio
- 6.7.5 Sanofi Recent Developments
- 6.8 Teva Pharmaceuticals
- 6.8.1 Teva Pharmaceuticals Company Information
- 6.8.2 Teva Pharmaceuticals Business Overview
- 6.8.3 Teva Pharmaceuticals Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Teva Pharmaceuticals Cinnarizine Tablets Product Portfolio
- 6.8.5 Teva Pharmaceuticals Recent Developments
- 6.9 Torrent Pharmaceuticals
- 6.9.1 Torrent Pharmaceuticals Company Information
- 6.9.2 Torrent Pharmaceuticals Business Overview
- 6.9.3 Torrent Pharmaceuticals Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Torrent Pharmaceuticals Cinnarizine Tablets Product Portfolio
- 6.9.5 Torrent Pharmaceuticals Recent Developments
- 6.10 Beijing Neptunus Zhongxin Pharmaceutical
- 6.10.1 Beijing Neptunus Zhongxin Pharmaceutical Company Information
- 6.10.2 Beijing Neptunus Zhongxin Pharmaceutical Business Overview
- 6.10.3 Beijing Neptunus Zhongxin Pharmaceutical Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Beijing Neptunus Zhongxin Pharmaceutical Cinnarizine Tablets Product Portfolio
- 6.10.5 Beijing Neptunus Zhongxin Pharmaceutical Recent Developments
- 6.11 Cisen Pharma
- 6.11.1 Cisen Pharma Company Information
- 6.11.2 Cisen Pharma Business Overview
- 6.11.3 Cisen Pharma Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Cisen Pharma Cinnarizine Tablets Product Portfolio
- 6.11.5 Cisen Pharma Recent Developments
- 6.12 Harbin Pharmaceutical Group
- 6.12.1 Harbin Pharmaceutical Group Company Information
- 6.12.2 Harbin Pharmaceutical Group Business Overview
- 6.12.3 Harbin Pharmaceutical Group Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Harbin Pharmaceutical Group Cinnarizine Tablets Product Portfolio
- 6.12.5 Harbin Pharmaceutical Group Recent Developments
- 6.13 Nanjing Baijingyu Pharmaceutical
- 6.13.1 Nanjing Baijingyu Pharmaceutical Company Information
- 6.13.2 Nanjing Baijingyu Pharmaceutical Business Overview
- 6.13.3 Nanjing Baijingyu Pharmaceutical Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Nanjing Baijingyu Pharmaceutical Cinnarizine Tablets Product Portfolio
- 6.13.5 Nanjing Baijingyu Pharmaceutical Recent Developments
- 6.14 Shanghai Xinyi Wanxiang Pharmaceutical
- 6.14.1 Shanghai Xinyi Wanxiang Pharmaceutical Company Information
- 6.14.2 Shanghai Xinyi Wanxiang Pharmaceutical Business Overview
- 6.14.3 Shanghai Xinyi Wanxiang Pharmaceutical Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Shanghai Xinyi Wanxiang Pharmaceutical Cinnarizine Tablets Product Portfolio
- 6.14.5 Shanghai Xinyi Wanxiang Pharmaceutical Recent Developments
- 6.15 CSPC
- 6.15.1 CSPC Company Information
- 6.15.2 CSPC Business Overview
- 6.15.3 CSPC Cinnarizine Tablets Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 CSPC Cinnarizine Tablets Product Portfolio
- 6.15.5 CSPC Recent Developments
7 North America by Country
- 7.1 North America Cinnarizine Tablets Sales by Country
- 7.1.1 North America Cinnarizine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Cinnarizine Tablets Sales by Country (2021-2026)
- 7.1.3 North America Cinnarizine Tablets Sales Forecast by Country (2027-2032)
- 7.2 North America Cinnarizine Tablets Market Size by Country
- 7.2.1 North America Cinnarizine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Cinnarizine Tablets Market Size by Country (2021-2026)
- 7.2.3 North America Cinnarizine Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Cinnarizine Tablets Sales by Country
- 8.1.1 Europe Cinnarizine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Cinnarizine Tablets Sales by Country (2021-2026)
- 8.1.3 Europe Cinnarizine Tablets Sales Forecast by Country (2027-2032)
- 8.2 Europe Cinnarizine Tablets Market Size by Country
- 8.2.1 Europe Cinnarizine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Cinnarizine Tablets Market Size by Country (2021-2026)
- 8.2.3 Europe Cinnarizine Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Cinnarizine Tablets Sales by Country
- 9.1.1 Asia-Pacific Cinnarizine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Cinnarizine Tablets Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Cinnarizine Tablets Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Cinnarizine Tablets Market Size by Country
- 9.2.1 Asia-Pacific Cinnarizine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Cinnarizine Tablets Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Cinnarizine Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Cinnarizine Tablets Sales by Country
- 10.1.1 South America Cinnarizine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Cinnarizine Tablets Sales by Country (2021-2026)
- 10.1.3 South America Cinnarizine Tablets Sales Forecast by Country (2027-2032)
- 10.2 South America Cinnarizine Tablets Market Size by Country
- 10.2.1 South America Cinnarizine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Cinnarizine Tablets Market Size by Country (2021-2026)
- 10.2.3 South America Cinnarizine Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Cinnarizine Tablets Sales by Country
- 11.1.1 Middle East and Africa Cinnarizine Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Cinnarizine Tablets Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Cinnarizine Tablets Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Cinnarizine Tablets Market Size by Country
- 11.2.1 Middle East and Africa Cinnarizine Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Cinnarizine Tablets Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Cinnarizine Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Cinnarizine Tablets Value Chain Analysis
- 12.1.1 Cinnarizine Tablets Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Cinnarizine Tablets Production Mode & Process
- 12.2 Cinnarizine Tablets Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Cinnarizine Tablets Distributors
- 12.2.3 Cinnarizine Tablets Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst